Skip to main content

Advertisement

Log in

Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection?

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Management of patients with synchronous hepatic metastases as the sole metastatic site at diagnosis of gastric cancer is debated. We studied a cohort of patients admitted to surgical units, investigating prognostic factors of clinical relevance and the results of various therapeutic strategies.

Methods

Retrospective multicentre chart review. We evaluated how survival from surgery was influenced by patient-related, gastric cancer-related, metastasis-related and treatment-related candidate prognostic factors.

Results

Forty-four patients received palliative surgery without resection, 98 palliative gastrectomy (in 16 cases associated with R+ hepatectomy), whereas 53 patients received both curative gastrectomy and hepatic resection(s) (R0). Adjuvant chemotherapy was administered to 44 patients. Therapeutic approach was selected on the basis of extension of disease, patient’s general conditions and surgeon’s attitude. Surgical mortality was 4.6 % and morbidity was 17.4 %. Survival was independently influenced by the factor T of the gastric primary (p = 0.036) and by the degree of hepatic involvement (p = 0.010). T > 2 and H3 liver involvement were associated with worse prognosis with cumulative effect (p = 0.002). Therapeutic approach to the metastases (p = 0.009) and adjuvant chemotherapy (p < 0.001) displayed independent impact upon survival, with benefit for those receiving aggressive multimodal treatment. The 1-, 3-, and 5-year survival rates were 50.4, 14.0, and 9.3 %, respectively, for patients submitted to curative surgery, 16, 8.5, and 4.3 % after palliative gastrectomy, and 6.8, 2.3, and 0 % after palliative surgery without resection.

Conclusions

Our data suggest some clinical criteria that may facilitate selection of candidates to curative surgery, which offers the best survival chances, especially when associated with adjuvant chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adam R, Chiche L, Aloia T, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg. 2006;244:524–35.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Lehner F, Ramackers W, Bektas H, et al. Liver resection for non-colorectal, non-neuroendocrine liver metastases—is hepatic resection justified as part of the oncosurgical treatment? Zentralbl Chir. 2009;134:430–6.

    Article  CAS  PubMed  Google Scholar 

  3. Ochiai T, Sasako M, Mizuno S, et al. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg. 1994;81:1175–8.

    Article  CAS  PubMed  Google Scholar 

  4. Ueda K, Iwahashi M, Nakamori M, et al. Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer. Langenbecks Arch Surg. 2009;394:647–53.

    Article  PubMed  Google Scholar 

  5. Okano K, Maeba T, Ishimura K, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg. 2002;235:86–91.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Hwang S-E, Yang D-H, Kim C-Y. Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer. World J Surg. 2009;33:1468–72.

    Article  PubMed  Google Scholar 

  7. Tiberio GAM, Coniglio A, Marchet A, et al. Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. Eur J Surg Oncol. 2009;35:486–91.

    Article  CAS  PubMed  Google Scholar 

  8. Makino H, Kunisaki C, Izumisawa Y, et al. Indication for hepatic resection in the treatment of liver metastasis from gastric cancer. Anticanc Res. 2010;30:2367–76.

    Google Scholar 

  9. Ambiru S, Miyazaki M, Ito H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg. 2001;181:279–83.

    Article  CAS  PubMed  Google Scholar 

  10. Miyazaki M, Itoh H, Nakagawa K, et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol. 1997;92:490–93.

    CAS  PubMed  Google Scholar 

  11. Shirabe K, Shimada M, Matsumata T, et al. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology. 2003;50:1560–3.

    PubMed  Google Scholar 

  12. Sakamoto Y, Sano T, Shimada K, et al. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol. 2007;95:534–9.

    Article  PubMed  Google Scholar 

  13. Thelen A, Jonas S, Benckert C, et al. Liver resection for metastatic gastric cancer. Eur J Surg Oncol. 2008;34:1328–34.

    Article  CAS  PubMed  Google Scholar 

  14. Tsujimoto H, Ichikura T, Ono S, et al. Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int. 2010;4:406–13.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Garancini M, Uggeri F, Degrate L, et al. Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile? HPB. 2012;14:209–15.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Schildberg CW, Croner R, Merkel S, et al. Outcome of operative therapy of hepatic metastatic stomach carcinoma: a retrospective analysis. World J Surg. 2012;36:872–8.

    Article  PubMed  Google Scholar 

  17. Miki Y, Fujitani K, Hirao M, et al. Significance of surgical treatment of liver metastases from gastric cancer. Anticancer Res. 2012;32:665–70.

    PubMed  Google Scholar 

  18. Takemura N, Saiura A, Koga R, et al. Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg. 2012;397:951–7.

    Article  PubMed  Google Scholar 

  19. Liu J, Li JH, Zhai RJ, et al. Predictive factors improving survival after gastric and hepatic surgical treatment in gastric cancer patients with synchronous liver metastases. Chin Med J (Engl). 2012;125:165–71.

    PubMed  Google Scholar 

  20. Dicken BJ, Bigam DL, Cass C, et al. Gastric adenocarcinoma. Review and considerations for future directions. Ann Surg. 2005;241:27–39.

    PubMed Central  PubMed  Google Scholar 

  21. Liu J, Chen L. Current status and progress in gastric cancer with liver metastasis. Chin Med J (Engl). 2011;124:445–56.

    PubMed  Google Scholar 

  22. Tiberio GAM, Portolani N, Giulini SM. Hepatic metastases from gastric cancer. In: Mahmoud L, editor. Gastric carcinoma—molecular aspects and current advances. InTech. 2011. doi:10.5772/16638.

  23. Kerkar SP, Kemp CD, Avital I. Liver resections in metastatic gastric cancer. HPB. 2010;12:589–96.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Chiche L, Ducreux M, Lebreton G, et al. Métastases hépatiques des cancers de l’estomac. In: Adam R, Chiche L, editors. Chirurgie des métastases hépatiques de cancers non colorectaux non endocrine. Monographies de l’association Française de Chirurgie. Paris: Arnette; 2005. p. 45–9.

  25. Edge SB, Byrd DR, Compton CC, eds. AJCC cancer staging manual. 7th ed. New York, NY: Springer; 2010.

    Google Scholar 

  26. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English ed. Gastric Cancer. 2011;14:101–12.

    Article  Google Scholar 

  27. Marrelli D, De Stefano A, de Manzoni G, et al. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247–55.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Imamura H, Matsuyama Y, Shimada R, et al. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol. 2001;96:3178–84.

    Article  CAS  PubMed  Google Scholar 

  29. Roh HR, Suh KS, Lee HJ, et al. Outcome of hepatic resection for metastatic gastric cancer. Am Surg. 2005;71:95–9.

    PubMed  Google Scholar 

  30. Yang XW, Li Z, Liu K, et al. Correlation between the survival rate of the patients with synchronous hepatic metastases from gastric carcinoma after surgical resection and patient’s index. Chin Med J. 2012;125:747–51.

    PubMed  Google Scholar 

  31. Wang YN, Shen KT, Ling JQ, et al. Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases. BMC Surg. 2012;12:20.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Shirabe K, Wakiyama S, Gion T, et al. Hepatic resection for the treatment of liver metastases in gastric carcinoma: review of the literature. HPB. 2006;8:89–92.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Cheon SH, Rha SY, Jeung H-C, et al. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol. 2008;19:1146–153.

    Article  CAS  PubMed  Google Scholar 

  34. Kim HR, Cheon SH, Lee KH, et al. Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma. Int J Hyperthermia. 2010;26:305–15.

    Article  PubMed  Google Scholar 

  35. Misleh JG, Santoro P, Strasser JF, et al. Multidisciplinary management of gastric cancer. Surg Oncol Clin N Am. 2013;22:247–64.

    Article  PubMed  Google Scholar 

  36. Hartgrink HH, Putter H, Klein Kranenbarg E, et al. Value of palliative resection in gastric cancer. Br J Surg. 2002;89:1438–43.

    Article  CAS  PubMed  Google Scholar 

  37. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.

    Article  Google Scholar 

Download references

Acknowledgment

The authors are grateful to Mr. Richard Humphies (BA Hons English Literature) for his precious help in revising the English language of the manuscript.

Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guido Alberto Massimo Tiberio MD.

Additional information

On behalf of the Italian Research Group for Gastric Cancer.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 84 kb)

Supplementary material 2 (DOCX 18 kb)

Supplementary Fig. 1

Effect of chemotherapy. A Survival according to chemotherapy. B Cumulative survival according to the number of negative prognostic factors related to gastric primary (T > 2) and hepatic involvement (H3). Supplementary material 3 (TIFF 60 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tiberio, G.A.M., Baiocchi, G.L., Morgagni, P. et al. Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection?. Ann Surg Oncol 22, 589–596 (2015). https://doi.org/10.1245/s10434-014-4018-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-014-4018-6

Keywords

Navigation